Michael David Garrison - 26 Nov 2024 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Role
EVP & President, Medical
Signature
Donna Kalazdy, by power of attorney for Michael David Garrison
Issuer symbol
BDX
Transactions as of
26 Nov 2024
Net transactions value
$0
Form type
4
Filing time
29 Nov 2024, 09:59:24 UTC
Previous filing
01 May 2024
Next filing
20 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDX Common Stock Award $0 +2,553 +47% $0.000000 7,934 26 Nov 2024 Direct F1
transaction BDX Common Stock Award $0 +2,275 +29% $0.000000 10,209 26 Nov 2024 Direct F2
transaction BDX Common Stock Tax liability $0 -1,230 -12% $0.000000 8,979 26 Nov 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDX Stock Appreciation Rights Award $0 +10,004 $0.000000 10,004 26 Nov 2024 Common Stock 10,004 $224.25 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2 Represents shares received upon vesting of performance based equity award.
F3 Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units as previously reported on Table I.
F4 The stock appreciation rights vest in four annual installments beginning November 26, 2025.